Skip to main content

Biocon: Fresh biosimilar opportunities to give a boost to its US prospects

The insulin patent win and filing of another oncology biosimilar in the US to drive earnings

from Companies https://ift.tt/2wvUHm7
via IFTTT

Comments

Popular posts from this blog